advertisement
Abstract #13415 Published in IGR 8-1
Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma
Costagliola C; Parmeggiani F; Caccavale A; Sebastiani AAmerican Journal of Ophthalmology 2006; 141: 379-381
See also comment(s) by Thom Zimmerman •
PURPOSE: To verify the short-term influence of an orally administered nonsteroidal anti-inflammatory drug on the intraocular pressure (IOP) of primary open-angle glaucoma patients in therapy with a topical prostaglandin analog. DESIGN: Randomized cross-over double-blind study. METHODS: Sixteen adults with primary open-angle glaucoma, receiving 0.005% latanoprost eyedrops once daily, were treated with a single dose of either 100 mg nimesulide or placebo. IOP was recorded at baseline and at 1, 2, 4, 8, 12, and 24 hours. RESULTS: After nimesulide administration, there was a decrease in IOP (with a fall at the second hour, P < .01) that remained significant 8 hours later (P < .05). At 12 and 24 hours, there were unremarkable IOP differences between the two regimens. CONCLUSIONS: In patients with primary open-angle glaucoma, single-dose nimesulide significantly enhances the latanoprost-induced IOP-lowering effects during the short plasma half-life of this non-steroidal anti-inflammatory drug.
Dr. C. Costagliola, Department of Ophthalmology, University of Ferrara, and Neuro-ophthalmology and Ocular Immunology Service, Magenta and Abbiategrasso General Hospital, Italy
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)
11.15 Other drugs in relation to glaucoma (Part of: 11 Medical treatment)
